Страна: Соединенные Штаты
Язык: английский
Источник: NLM (National Library of Medicine)
CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H)
Actavis Pharma, Inc.
CLOBETASOL PROPIONATE
CLOBETASOL PROPIONATE 0.05 g in 1 mL
TOPICAL
PRESCRIPTION DRUG
Clobetasol Propionate Spray, 0.05% is a super-high potent topical corticosteroid formulation indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older. Patients should be instructed to use Clobetasol Propionate Spray, 0.05% for the minimum amount of time necessary to achieve the desired results [see Dosage and Administration (2) ]. Use in patients under 18 years of age is not recommended because safety has not been established and because numerically high rates of HPA axis suppression were seen with other clobetasol propionate topical formulations. [see Use in Specific Populations (8.4) ]. Clobetasol Propionate Spray, 0.05% should not be used on the face, axillae, or groin. Clobetasol Propionate Spray, 0.05% should not be used if there is atrophy at the treatment site. Clobetasol Propionate Spray, 0.05% should not be used in the treatment of rosacea or perioral dermatitis. None. Risk Summary There are no availabl
Clobetasol Propionate Spray, 0.05% is a clear, colorless liquid supplied in a white HDPE bottle with a white polypropylene cap and white LDPE liner in the following sizes: 2 fl oz/59 mL NDC 0591-4039-46 4.25 fl oz/125 mL NDC 0591-4039-74 Storage: Keep tightly closed. Store under controlled room temperature conditions 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). Do not freeze, refrigerate or store above 30°C. Spray is flammable; avoid heat, flame or smoking when using this product.
New Drug Application Authorized Generic
CLOBETASOL PROPIONATE- CLOBETASOL PROPIONATE SPRAY ACTAVIS PHARMA, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE CLOBETASOL PROPIONATE SPRAY, 0.05% SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR CLOBETASOL PROPIONATE SPRAY, 0.05%. CLOBETASOL PROPIONATE SPRAY, FOR TOPICAL USE. INITIAL U.S. APPROVAL: 1985 INDICATIONS AND USAGE Clobetasol Propionate Spray, 0.05% is a corticosteroid indicated for the topical treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older. (1.1) Limitations of Use: Do not use on the face, axillae or groin. (1.2) Do not use if atrophy is present at the treatment site. (1.2) Do not use for rosacea or perioral dermatitis. (1.2) DOSAGE AND ADMINISTRATION Not for oral, ophthalmic, or intravaginal use. (1.2) Spray directly onto the affected skin areas twice daily and rub in gently. (2) The total dosage should not exceed 50 g (59 mL or 2 fluid ounces) per week. Do not use more than 26 sprays per application or 52 sprays per day. (2) Treatment beyond 2 weeks should be limited to localized lesions of moderate to severe plaque psoriasis that have not sufficiently improved after the initial 2 weeks of treatment with Clobetasol Propionate Spray, 0.05%. (2) Do not use for more than 4 weeks. (2) DOSAGE FORMS AND STRENGTHS Spray, 0.05% w/w (3) CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS Clobetasol propionate is a highly potent topical corticosteroid that has been shown to suppress the HPA axis at the lowest doses tested. (5.1) Cushing’s syndrome, hyperglycemia, and unmasking of latent diabetes mellitus can also result from systemic absorption of topical corticosteroids. (5.1) Systemic absorption may require periodic evaluation for HPA axis suppression. Modify use if HPA axis suppression develops. (5.1) Children may be more susceptible to systemic toxicity from use of topical corticosteroids. (5.1, 8.4) Clobetasol propionate spray may inc Прочитать полный документ